Angela M. Cacace, Chief Scientific Officer at ARVINAS, INC. (ARVN), sold 7,268 shares at $16.75 ($122K) on 2025-02-24, disclosed to the SEC on 2025-02-25.
Open-market sale of $122k ARVN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.55 | 1,146 | $19K | 15.6% |
| 2 | $16.75 | 3,061 | $51K | 42.2% |
| 3 | $16.75 | 3,061 | $51K | 42.2% |
| Total | $16.72 avg | 7,268 | $122K | 100% |
| Filing → |
| ARVN | SELL | 2026-02-25 | $44K | — | Filing → |
| ARVN | SELL | 2026-02-18 | $55K | — | Filing → |
| ARVN | SELL | 2025-06-18 | $19K | — | Filing → |